Gomez, Daniel R <br/><br/>
Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Jul 2013 
 - 665-70 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1879-355X 
<br/><br/><label>Standard No.: </label>10.1016/j.ijrobp.2013.03.035  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cetuximab<br/>Dose Fractionation, Radiation<br/>Esophagitis--etiology<br/>Esophagus--radiation effects<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Lymphatic Irradiation--methods<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Organs at Risk--radiation effects<br/>Prospective Studies<br/>Proton Therapy--adverse effects<br/>Radiation Pneumonitis--etiology<br/>Relative Biological Effectiveness